Cancer Behavior Inventory–Brief Version (CBI-B)

Cancer Behavior Inventory–Brief Version (CBI-B)
Heitzmann et al.‚ 2011
 
1.    Maintaining independence
2.    Maintaining a positive attitude
3.    Maintaining a sense of humor
4.    Expressing feelings about cancer
5.    Putting things out of my mind at times
6.    Maintaining activities (work‚ home‚ hobbies‚ social)
7.    Trying to be calm throughout treatments and not allowing scary thoughts to upset me
8.    Actively participating in treatment decisions
9.    Asking physicians questions
10.Seeking social support
11.Sharing my worries or concerns with others
12.Managing nausea and vomiting (whether or not I have had these problems in the past)
13.Coping with physical challenges
14.Trying to be calm while waiting at least one hour for my appointment
 
1= not at all confident‚ to 9= totally confident
 
This instrument can be found at: http://europepmc.org/articles/pmc2945365#R4
 

Merluzzi‚ T.V.‚ Martinez-Sanchez‚ M.A. (1997). Assessment of self-efficacy in coping with cancer: Development and validation of the cancer behavior inventory. Health Psychology‚ 16‚ 1–8.

Merluzzi‚ T.V.‚ Nairn‚ R.C.‚ Hegde‚ K.‚ Martinez Sanchez‚ M.A.‚ Dunn‚ L. (2001). Self-efficacy and coping with cancer: Revision of the Cancer Behavior Inventory (Version 2.0). Psycho-Oncology‚ 10(3)‚ 206–217.

Heitzmann‚ C. A.‚ Merluzzi‚ T. V.‚ Jean-Pierre‚ P.‚ Roscoe‚ J. A.‚ Kirsh‚ K. L.‚ & Passik‚ S. D. (2011). Assessing self-efficacy for coping with cancer: Development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psycho-Oncology‚ 20(3)‚ 302–312.

Heitzmann et al.‚ (2011). Cancer Behavior Inventory–Brief Version. In: Simmons C. A.‚ Lehmann P. (eds). Tools for strengths-based assessment and evaluation‚ New York‚ NY: Springer‚ pp. 295-297. (2013).Google Scholar

Chirico‚ A.‚ Lucidi‚ F.‚ Merluzzi‚ T.‚ Alivernini‚ F.‚ et al. (2017). A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life‚ Oncotarget‚ 8‚36800-36811. doi: 10.18632/oncotarget.15758